Skip to Content

Join the 'Tuberculosis - Latent' group to help and get support from people like you.

Tuberculosis - Latent News

Related terms: Latent Tuberculosis

Global Efforts to Combat TB Epidemic Falling Short

Posted 13 Oct 2016 by Drugs.com

THURSDAY, Oct. 13, 2016 – Countries around the world need to work harder to combat tuberculosis infections and deaths, a new World Health Organization report says. Nations across the globe have pledged to reduce tuberculosis (TB) infections by 80 percent and TB deaths by 90 percent by 2030, but they must work faster if they want to meet these goals, according to the WHO. "We face an uphill ...

Tuberculosis Decline in U.S. Has Stalled, CDC Reports

Posted 24 Mar 2016 by Drugs.com

THURSDAY, March 24, 2016 – Two decades of progress toward eliminating tuberculosis in the United States has stalled, with incidence of the lung disease holding steady from 2013 to 2015, a federal government report shows. "Resuming progress toward TB elimination in the United States will require intensification of efforts both in the U.S. and globally," said researchers from the U.S. Centers for ...

Screen High-Risk Adults for Tuberculosis, Experts Say

Posted 8 Mar 2016 by Drugs.com

TUESDAY, March 8, 2016 – Adults at greater risk for latent tuberculosis infection should be screened for the condition, the U.S. Preventive Services Task Force recommends. "The task force recommends that primary care clinicians screen adults at increased risk for [latent TB] to help prevent the progression to active TB," panel member Dr. Francisco Garcia said in a task force news release. Garcia ...

New TB Test May Help Simplify Diagnosis

Posted 20 Feb 2016 by Drugs.com

FRIDAY, Feb. 19, 2016 – A simple new blood test for tuberculosis may one day help improve diagnosis and treatment of the deadly disease in developing countries, researchers report. The inexpensive test identifies a gene expression "signature" that distinguishes people with active TB from those with either latent TB or other diseases, according to the research team from the Stanford University ...

TB Cases Falling for Foreign-Born People in U.S.

Posted 10 Feb 2016 by Drugs.com

WEDNESDAY, Feb. 10, 2016 – Tuberculosis cases among foreign-born people in the United States fell by one-fifth in recent years, and the reasons for the decline depend on people's country of origin, a new study suggests. Tuberculosis (TB) is a bacterial infection affecting the lungs and sometimes other organs. Overall, TB cases in the United States decreased over the past two decades, but TB ...

Toxic Chemicals May Weaken Infants' Response to TB Vaccine

Posted 18 Dec 2015 by Drugs.com

FRIDAY, Dec. 18, 2015 – Exposure to toxic chemicals while in the womb or in early life may weaken a baby's immune system response to the tuberculosis (TB) vaccine, researchers say. The study focused on two common toxins: PCBs, an industrial chemical; and DDT, used in pesticides. These so-called "persistent" pollutants are not easily broken down and remain a health threat years after being ...

Assessing Health Issues of Child Refugees

Posted 29 Nov 2015 by Drugs.com

FRIDAY, Nov. 27, 2015 – The main health problems of refugee children from Asia and Africa when they arrive in the United States are outlined in a new study. Based on screenings of more than 8,100 young refugees between 2006 and 2012, the top health concerns were hepatitis B, tuberculosis, parasitic worms, high blood lead levels and anemia, the study found. The refugees, all younger than 19, were ...

Doctors Save Life of U.S. Child With Drug-Resistant Tuberculosis

Posted 16 Nov 2015 by Drugs.com

SUNDAY, Nov. 15, 2015 – A 5-year-old child from the United States, stricken at age 2 with a deadly form of tuberculosis after traveling to India, is finally in remission, researchers report. The case, one of only a handful reported in the medical literature, highlights the difficulties of treating an extensively drug-resistant form of tuberculosis, known as XDR TB, in children, the researchers ...

Swiss Report Highlights Danger of Drug-Resistant Tuberculosis

Posted 11 Nov 2015 by Drugs.com

WEDNESDAY, Nov. 11, 2015 – A new report on a patient in Switzerland who nearly died after catching a highly drug-resistant strain of tuberculosis illustrates exactly what public health officials around the world fear most. Although antibiotics have largely eradicated tuberculosis in the United States in recent decades, experts say evidence is mounting that the bacteria is becoming increasingly ...

U.S. Health Officials Search for Those Exposed to Drug-Resistant TB

Posted 9 Jun 2015 by Drugs.com

TUESDAY, June 9, 2015 – U.S. health authorities are trying to find anyone who may have had contact with a woman who has been diagnosed with a highly drug-resistant form of tuberculosis. The woman flew from India to Chicago in April. She then traveled to Missouri and Tennessee before returning to Chicago, where she sought treatment at a hospital about seven weeks after arriving in the United ...

18th Century Mummies Reveal How TB Spread Through Europe

Posted 8 Apr 2015 by Drugs.com

WEDNESDAY, April 8, 2015 – Naturally mummified bodies from an 18th century crypt in Hungary provide new insight into tuberculosis infections in Europe during that time, researchers say. The discovery could also help health officials fight future tuberculosis (TB) outbreaks, the scientists suggested. Analyses of samples taken from the bodies in the crypt in the Dominican church of Vac uncovered ...

Sanofi Receives FDA Approval of Priftin (rifapentine) for Latent Tuberculosis Infection

Posted 2 Dec 2014 by Drugs.com

Bridgewater, NJ – December 2, 2014 / PR Newswire / — Sanofi announced today that following a priority review, the U.S. Food and Drug Administration has approved Priftin (rifapentine) in combination with isoniazid (INH) for a new indication for the treatment of latent tuberculosis infection (LTBI) in patients two years of age and older at high risk of progression to tuberculosis (TB) disease. Pri ...

CDC Issues New TB Treatment Guidelines

Posted 8 Dec 2011 by Drugs.com

THURSDAY, Dec. 8 – New guidelines on treating so-called "latent" tuberculosis infection in the United States should significantly shorten and simplify the course of the therapy from about 9 months to 3 months, according to the U.S. Centers for Disease Control and Prevention. The new guidelines for public health officials and health care providers – which are based on expert opinion and the ...

New TB Vaccine Passes Safety Trial

Posted 8 Apr 2009 by Drugs.com

WEDNESDAY, April 8 – An experimental tuberculosis vaccine called MVA85A proved safe in a small phase I clinical trial. The study included 12 people with latent tuberculosis infection, which, when re-activated, can cause full-blown TB. It's believed that about a third of the world's population has this latent infection. The participants, who had no other complicating factors, such as hepatitis or ...

Ask a Question

Further Information

Related Condition Support Groups

Tuberculosis

Related Drug Support Groups

isoniazid, rifampin, pyrazinamide, rifapentine, Nydrazid, Rifadin, Rifadin IV, Priftin, Rimactane